Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Urovant Sciences Ltd. | urov-ex322_8.htm |
| EX-32.1 - EX-32.1 - Urovant Sciences Ltd. | urov-ex321_14.htm |
| EX-31.2 - EX-31.2 - Urovant Sciences Ltd. | urov-ex312_13.htm |
| EX-31.1 - EX-31.1 - Urovant Sciences Ltd. | urov-ex311_11.htm |
| EX-21.1 - EX-21.1 - Urovant Sciences Ltd. | urov-ex211_9.htm |
| EX-10.22 - EX-10.22 - Urovant Sciences Ltd. | urov-ex1022_123.htm |
| EX-4.3 - EX-4.3 - Urovant Sciences Ltd. | urov-ex43_12.htm |
| 10-K - 10-K - Urovant Sciences Ltd. | urov-10k_20200331.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following the Registration Statements:
|
(1) |
Registration Statement (Form S-8 No. 333-227593) pertaining to the Urovant Sciences Ltd. 2017 Equity Incentive Plan, as amended and restated, |
|
(2) |
Registration Statement (Form S-8 No. 333-228386) pertaining to the Urovant Sciences Ltd. 2017 Equity Incentive Plan, as amended and restated, |
|
(3) |
Registration Statement (Form S-3 No. 333-234620) of Urovant Sciences Ltd., and |
|
(4) |
Registration Statement (Form S-8 No. 333-234621) pertaining to the Urovant Sciences Ltd. 2017 Equity Incentive Plan, as amended and restated and the Urovant Sciences Ltd. 2019 Employee Stock Purchase Plan; |
of our report dated June 19, 2020, with respect to the consolidated financial statements of Urovant Sciences Ltd. included in this Annual Report (Form 10-K) of Urovant Sciences Ltd. for the year ended March 31, 2020.
/s/ Ernst & Young LLP
Irvine, California
June 19, 2020